Affordable Access

Combination chemotherapy and radiation for stage IV breast cancer during pregnancy.

Authors
  • Willemse, P H
  • van der Sijde, R
  • Sleijfer, D T
Type
Published Article
Journal
Gynecologic oncology
Publication Date
Feb 01, 1990
Volume
36
Issue
2
Pages
281–284
Identifiers
PMID: 2298417
Source
Medline
License
Unknown

Abstract

A 42-year-old woman presented with a 25-week pregnancy and stage IV breast cancer with metastases in the skeleton and liver and a T-4 primary tumor. She was treated with two cycles of doxorubicin, methotrexate, and vincristine. Spontaneous labor resulted in a normal female infant, who was successfully treated for sepsis and mild respiratory distress. The placenta showed diffuse chorioamnionitis. There was no doxorubicin demonstrated in the placenta, blood, or fetal lymphocytes 3 weeks after the last treatment. Maternal and fetal chromosomal analyses were unremarkable. The child is functioning normally 2 years after delivery. The literature on anthracycline treatment during pregnancy is reviewed. Adriamycin has been shown to cross the blood-placenta barrier, but has not led to specific fetal abnormalities when given during the second or third trimester. Experience during the first trimester is still limited.

Report this publication

Statistics

Seen <100 times